ImpoPharma

About:

Impopharmas drug development expertise means new product opportunities for its clients.

Top Investors: Venrock, Armentum Partners

Description:

Impopharma offers comprehensive drug product formulation and process development, as well as wide-ranging analytical testing services to the pharmaceutical industry, specializing in nasal and pulmonary drug products.

Total Funding Amount:

$7M

Headquarters Location:

Concord, Ontario, Canada

Founded Date:

1996-01-01

Contact Email:

info(AT)impopharma.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2016-01-01

IPO Status:

Private

Industries: